Beyond psilocybin and LSD, the classic psychedelics include DMT and the ayahuasca brew, mescaline, and the mescaline-containing cacti peyote and San Pedro. They are all 5-HT2A agonists, [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 but they share a more important feature for this site: they are largely not microdosed and have essentially no controlled low-dose evidence. [2] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 DMT is orally inactive without an enzyme inhibitor and extremely short-acting alone, which is why ayahuasca exists as a full-dose preparation; [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101 mescaline is low-potency and long-lasting. [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215 This page describes what these compounds are at a research-literacy level and explains why low-dose use is uncommon — it is not a guide to sourcing, harvesting, preparing, or dosing any of them.
This is an education-only research review, not sourcing, dosing, foraging, preparation, medical, or legal advice. It identifies these compounds and preparations and describes why they are rarely microdosed. It does not explain how to obtain, grow, harvest, extract, or use them, and it issues no safe-or-unsafe verdict. Several carry conservation, cultural, and interaction concerns noted below. For personal decisions, consult a qualified clinician.
DMT and ayahuasca
N,N-dimethyltryptamine is a tryptamine and, structurally, the archetype of the serotonergic psychedelics — its skeleton is embedded in both psilocybin and LSD. [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101 Two facts make it a poor microdosing candidate and explain its place in the literature. First, it is rapidly degraded by monoamine oxidase, so it is essentially inactive when swallowed alone. Second, by other routes it is extremely short-acting and intense. Ayahuasca is the traditional solution to the first problem: a brew combining a DMT-containing plant with another that inhibits monoamine oxidase, rendering the DMT orally active. [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101
That combination is itself a pharmacological interaction with its own risk profile, and ayahuasca is studied and used as a full-dose, supervised, ceremonial practice — not a sub-perceptual one. Ayahuasca is not simply DMT: it is a psychoactive preparation involving DMT-containing plants and MAOI-containing plants, and that pairing changes the pharmacology, duration, interaction risk, and cultural context relative to DMT alone. Interaction and risk specifics belong to the safety and interactions clusters, not here. A separate related compound, 5-MeO-DMT, is often confused with DMT but is a distinct tryptamine with a different profile and is likewise not a microdosing substance.
Mescaline and the cacti
Mescaline is a phenethylamine — the same broad chemical family as the amphetamines and MDMA — yet pharmacologically a classic 5-HT2A-agonist psychedelic, a good illustration that chemical family does not dictate subjective category. [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215 It is comparatively low in potency, requiring much larger amounts than psilocybin or LSD, and lasts many hours. Archaeological evidence places cactus use over thousands of years. [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215
Mescaline occurs in several cacti. Peyote (genus Lophophora) is a small, slow-growing North American cactus; San Pedro is a tall, fast-growing South American columnar cactus. They differ botanically and in alkaloid concentration. Peyote and San Pedro are biological materials, not fixed-dose pharmaceutical preparations: alkaloid content can vary, accompanying compounds differ, and a plant is not a standardised quantity. Peyote in particular has specific Indigenous cultural and legal significance and should not be flattened into a generic “mescaline source” — it is slow-growing, has been overharvested, and holds sacramental status for Indigenous communities, which places it outside any casual-use framing. None of this section is sourcing or harvesting guidance; identifying the plants is a research-literacy point, not an invitation to obtain them.
| Compound / preparation | What it is | Why rarely microdosed |
|---|---|---|
| DMT | Tryptamine; orally inactive alone | Short, intense; needs an MAOI to work orally |
| Ayahuasca | DMT plant + MAOI plant brew | A full-dose ceremonial practice by design |
| 5-MeO-DMT | Distinct related tryptamine | Extremely intense; almost no low-dose research |
| Mescaline | Phenethylamine psychedelic | Low potency, very long duration |
| Peyote / San Pedro | Mescaline-containing cacti | Conservation, cultural, and potency concerns |
Why “classic” does not mean “microdosed”
It is easy to assume that any serotonergic psychedelic is a plausible microdosing substance. The evidence says otherwise. A systematic review found the microdosing field thin and concentrated almost entirely in psilocybin and LSD; the compounds on this page appear in full-dose, pharmacological, and anthropological work, not in controlled low-dose studies. [2] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 For these substances, the compound is described far better than any microdosing effect, and absence of low-dose evidence is not evidence that low doses do anything — there is simply very little to go on.
| Reasonably described | Largely absent |
|---|---|
| Chemistry, class, receptor target | Controlled microdosing trials |
| Full-dose pharmacology and duration | Low-dose dose-response data |
| Traditional and ceremonial use | Repeated low-dose safety data |
Holding the distinctions
The distinctions apply with extra force here. Full-dose is not microdose: what little is known is from full, often ceremonial doses, and does not transfer to sub-perceptual use. Plausibility is not demonstrated efficacy: a shared receptor makes a microdose effect conceivable, not shown. And the guardrail is firm: this is identity and context, not instruction. For how the shared mechanism works see the pharmacology overview; for substances people confuse with these, atypical and adjacent substances; for how thin the overall base is, what the research covers.
- DMT needs an MAOI orally
- Monoamine oxidase degrades DMT, so ayahuasca pairs it with an enzyme inhibitor — a full-dose practice. [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101
- Family ≠ effect
- Mescaline is a phenethylamine yet a classic 5-HT2A psychedelic; chemical family does not predict experience. [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215
- Cacti differ
- Peyote (Lophophora) and San Pedro are distinct mescaline cacti with conservation and cultural concerns.
- Classic ≠ microdosed
- Being a 5-HT2A psychedelic does not make a substance a studied microdosing candidate. [2] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
Frequently asked questions
Are DMT, ayahuasca, and mescaline microdosed?
Rarely, and with essentially no controlled evidence. DMT on its own is extremely short-acting and orally inactive, ayahuasca is a full-dose ceremonial brew rather than a low-dose practice, and mescaline requires large amounts and lasts many hours. [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101 [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215 Surveys and the few microdosing trials are dominated by psilocybin and LSD; these other classic psychedelics appear mostly in full-dose, anthropological, or pharmacological literature. [2] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 This page describes what they are and why low-dose use is uncommon, not how to use them.
Why does DMT need to be combined with something to work orally?
DMT is rapidly broken down by the enzyme monoamine oxidase in the gut and liver, so swallowing it alone produces little effect. [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101 Ayahuasca traditionally combines a DMT-containing plant with another plant that inhibits that enzyme, allowing the DMT to become orally active. That combination is itself a pharmacological interaction with its own risks, which is one reason ayahuasca is a full-dose, supervised practice in the literature rather than anything resembling microdosing. Interaction and risk questions belong to the safety and interactions material.
What is the difference between peyote and San Pedro?
Both are mescaline-containing cacti. Peyote is a small, slow-growing North American cactus of the genus Lophophora; San Pedro is a tall, fast-growing South American columnar cactus. [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215 They differ botanically and in mescaline concentration, and peyote in particular carries significant conservation and cultural-protection concerns because of overharvesting and its sacramental use. This page identifies them at a research-literacy level; it does not cover sourcing, harvesting, or preparation, which are out of scope.
Is 5-MeO-DMT the same as DMT?
No. 5-MeO-DMT is a related but distinct tryptamine, found in some plants and famously in the secretion of a particular toad species, with a different receptor profile and an extremely intense, short full-dose experience. [3] Peer-reviewed Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT) doi:10.1021/acschemneuro.8b00101 It is not a microdosing substance and has little controlled human research. It is mentioned here only to distinguish it from DMT, because the names are easily confused; describing what it is is not an endorsement of using it.
Does mescaline have microdosing evidence like psilocybin?
No comparable evidence base has been established. Mescaline is a classic 5-HT2A psychedelic, [4] Peer-reviewed Dark Classics in Chemical Neuroscience: Mescaline doi:10.1021/acschemneuro.8b00215 but most microdosing research is concentrated around psilocybin and LSD, and mescaline appears mainly in full-dose, pharmacological, and anthropological work rather than controlled low-dose studies. [2] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 Being a classic psychedelic does not confer microdosing evidence — that has to be demonstrated compound by compound, and for mescaline it has not been. Its long duration and the variability of the cacti it comes from add further reasons the evidence question is different.